A federal judge has dismissed a proposed class action accusing Baxter International and Hospira of conspiring to manufacture an artificial shortage of intravenous saline solution in order to increase prices, reported Reuters.
US District Judge John Tharp in Chicago on Thursday agreed with the saline solution suppliers that plaintiffs’ theory that the companies used bogus product recalls to create the shortage was “quite implausible.”
Full Content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
